ArticleThe oncologist2026

Patients' and healthcare providers' views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study.

Dina N Lokhorst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.